
Case Study: How a Medical Device Manufacturer Stopped Losing Yield to Contamination
There is a version of this story that plays out more often than most manufacturers want to admit.
A growing medical device company is producing consistently — until it is not. Yield starts slipping. The quality team digs in. Processes are reviewed, operators are retrained, incoming materials are scrutinized. Everything checks out. The losses continue.
The problem, it turns out, is not what anyone is doing. It is where they are doing it.
This is the story of one manufacturer that found the root cause, fixed it, and came out the other side with a more reliable operation and the confidence to scale.
The Situation
The company was an established medical device manufacturer experiencing gradual but persistent yield losses. Contamination-related failures were showing up at final inspection — particulate contamination on components, inconsistent surface cleanliness, and occasional microbial findings that required investigation and disposition.
The immediate costs were visible: scrapped product, rework labor, delayed shipments. The less visible costs were significant too — engineering time spent on investigations that never resolved the underlying issue, quality resources pulled into corrective actions, and a growing hesitation to ramp production volume while the problem remained unsolved.
When the team took an honest look at their environment, the picture became clearer. Their manufacturing space had evolved over time — equipment had been added, workflows had shifted, and the areas where open product was handled had never been formally assessed against the contamination control requirements the products actually demanded. They were operating in a space that was clean by general standards, but not controlled to the level their products and process required.
The root cause was not operator error. It was not a materials issue. It was the environment.
The Decision to Address It
Making the decision to invest in a controlled environment is not always straightforward for a growing manufacturer. Capital is finite. Production cannot stop. And the scope of what is actually needed — what classification, what footprint, what systems — is not always obvious from the inside.
This manufacturer took a deliberate approach. Rather than guessing at a solution or defaulting to the most expensive option, they engaged MediClean early in the process to work through the problem together.
The first step was understanding what the environment actually needed to support. That meant looking at the specific processes happening in the space, the products being manufactured and their risk profile, the regulatory requirements that applied, and the team’s production goals both now and over the next several years. Classification requirements were assessed against actual process needs, not assumptions.
The outcome of that assessment was clear direction: a modular cleanroom solution designed around their workflow, sized appropriately for their current and near-term volume, and built to the classification their products required.
The Solution
MediClean designed and installed a modular cleanroom that gave the manufacturer a properly controlled environment for the critical steps in their production process — the areas where product was open, where components were handled, and where contamination risk was highest.
The modular approach was a deliberate choice. A traditional build-out would have meant longer lead times, higher upfront cost, and a less flexible result. The modular system was installed with minimal disruption to ongoing production, reached certification quickly, and was designed with future reconfiguration in mind.
Equally important was the full scope of contamination control addressed in the project. The cleanroom itself established the environmental baseline, but MediClean also worked with the manufacturer on the supplies, PPE, and cleaning protocols needed to maintain that baseline consistently. A cleanroom that is properly built but improperly maintained will not hold its classification. The two have to work together.
The Results
The impact was measurable and relatively fast to appear.
Contamination-related failures at final inspection dropped significantly in the months following installation. Rework volume declined. Investigations that had previously consumed quality and engineering resources became infrequent. The team could trace product through the process with greater confidence that environmental variability was no longer a factor.
Beyond the numbers, there was an operational shift that mattered just as much. The team stopped second-guessing their environment. Production decisions — including the decision to increase volume — could be made based on capacity and demand, not on uncertainty about whether the controlled space could support the output.
For a growing manufacturer, that confidence is not a soft benefit. It is a prerequisite for scaling.
What This Case Illustrates
Contamination-related yield loss is one of the more frustrating problems in regulated manufacturing precisely because it is easy to misdiagnose. When the environment is the variable, investigations focused on process, materials, or personnel rarely find the answer. The losses persist, the corrective actions close without resolution, and the costs accumulate quietly.
The pattern tends to show up in operations that have grown faster than their infrastructure. What worked as a startup-scale environment stops working at commercial scale. The space that was adequate for low-volume production becomes a liability as throughput increases and regulatory scrutiny intensifies.
Getting ahead of it requires an honest assessment of whether the environment is actually suited to the work being done inside it — not just clean by general standards, but controlled to the level the product demands.
Working with MediClean
MediClean partners with medical device and life science manufacturers to design, build, and support cleanroom environments that match real production requirements. The work starts with understanding your process, your products, and your compliance obligations — not with a standard solution applied to every situation.
For manufacturers dealing with unexplained yield losses, preparing for a production ramp, or moving into regulated manufacturing for the first time, the right conversation to have is an early one. The cost of getting the environment right upfront is nearly always lower than the cost of diagnosing and correcting contamination problems after the fact.
If any part of this story sounds familiar, we are glad to talk through it.
Call us at 833-766-2343, visit medicleaninc.com, or contact us online to start the conversation. >>>